Building access to the Regenstrief Institute is restricted through early 2021. More on our coronavirus precautions.
See our coronavirus precautions.

Indiana University Center for Aging Research at Regenstrief Institute Associate Director Babar Khan, M.D., M.S., has been treating patients in the intensive care unit (ICU) throughout the COVID-19 pandemic.  

Dr. Khan said many patients continue to suffer from mental, physical and emotional impairments after being released from the ICU, and those problems can persist for months. He shared his experience with national media, including Kaiser Health News.  

He reported that older adults in the ICU with COVID-19 are suffering from delirium 70 to 80 percent of the time. Seniors are especially susceptible to delirium, which is a sudden change in brain function, when they are hospitalized for serious illnesses. Delirium in older adults is associated with an increased risk of losing independence, developing dementia and death 

Dr. Khan said given the extent of delirium and mounting evidence of neurological damage from COVID-19, he expects to see an increase in the prevalence of ICU-acquired cognitive impairment.  

Even younger patients may face a long recovery after time spent in the ICU.  

Dr. Khan helped develop the critical care recovery center model, dedicated to long-term recovery from intensive care. He works with patients at Eskenazi Health after they have been discharged from the ICU to help them recover from physical, emotional and mental symptoms that continue to linger.  

Dr. Khan and his colleagues are also conducting research to prevent, diagnose and treat delirium.  

Read about cognitive impairment in COVID-19 survivors

Listen to Dr. Khan discuss ICU recovery in an episode of The Problem podcast from Regenstrief.  

In addition to his role at Regenstrief, Dr. Khan also serves as an associate professor of medicine at Indiana University School of Medicine and a physician at Eskenazi Health.  

Related Influence

Feb 10, 2021 • Expert Opinion, Influence
Black History and Sam Regenstrief: Working for civil rights through health equity
Photo courtesy of Eskenazi Health By NiCole Keith, PhD, Regenstrief Institute Research Scientist February is the celebration of Black History Month, which began when Black Americans from all over the United States traveled to Washington, D.C., to commemorate the 50th anniversary of the Emancipation Proclamation that freed Black people from institutional servitude and to celebrate the contributions…
Continue Reading >
Feb 08, 2021 • Influence
Natural language processing helps identify patients with chronic cough
Algorithm developed by Regenstrief and partners could help improve research into condition Researchers from Regenstrief Institute, Indiana University School of Medicine and Merck & Co. created and validated a natural language processing (NLP) algorithm to identify patients with chronic cough. The validation paper, published in Chest® Journal, is the first to use NLP to identify and examine this condition, and…
Continue Reading >